Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of BMI2006 vs Botox for Glabellar Lines
NCT05531968Phase 3Completed
- Sponsor
- BMI OrganBank
- Start
- Feb 2021
- Primary completion
- Aug 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A (BMI2006) in glabellar lines, sponsored by BMI OrganBank. Started Feb 2021; status: completed.
02
Drugs
botulinum toxin type A (BMI2006)
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT05531968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05531968.